$96m RNA Research and Manufacturing Facility opens in NSW

Intended to place New South Wales in a strong position in the fight against current and emerging diseases, the new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University Innovation Precinct has officially opened. The facility will aim to bolster domestic RNA manufacturing capability, attract investment, create local jobs and foster collaboration between universities, research institutes and industry.

The facility includes advanced laboratories and support spaces that will, the NSW Government said, make it the only site in Australia capable of producing a wide range of new and existing RNA therapeutics under one roof. The government also said that this facility “ensures NSW is better prepared for future pandemics by enabling the fast production of RNA vaccines and treatments when they are needed most”.

Delivered by Health Infrastructure in collaboration with the Office of the Chief Scientist & Engineer and builder Hindmarsh Constructions, Aurora Biosynthetics — industry partner and operator — will now engage with researchers and clients who aim to advance their therapeutic innovations from the laboratory towards clinical trials.

Image: Health Infrastructure